Key result
The Roche highly sensitive troponin T assay met precision specifications, detecting circulating troponin in 44 of 104 individuals from a cardio-healthy reference population.
Why the study?
What are the analytical characteristics of the Roche highly sensitive troponin T assay in a cardio-healthy population?
Observational (n=104)
What are the analytical characteristics of the Roche highly sensitive troponin T assay in a cardio-healthy population?
Answers are grounded in this paper and cite their sources.
The Roche hs-TnT assay demonstrates high precision and sensitivity, detecting troponin in many healthy individuals and highlighting the importance of clinical context in interpretation.
BACKGROUND: It is desirable that current assays for cardiac troponin (cTn) are able to meet the recommended criterion that the diagnosis and risk assessment of patients present with symptoms of myocardial infarction requires a rise and fall in cTn with at least one point above the 99th percentile of a reference population. We have evaluated the analytical characteristics of the new highly sensitive troponin T (hs-TnT) assay to see if it meets this criterion and applied it to a carefully defined, cardio-healthy Australian reference population. METHODS: An imprecision profile was determined for the Roche hs-TnT assay (Roche Diagnostics, Sydney, Australia) using multiple samples analysed on nine separate occasions. The distribution of troponin T was determined using 104 samples from a cardio-healthy population. RESULTS: The new hs-TnT assay meets the specifications of a coefficient of variation of 10% at the 99th percentile of our cardio-healthy reference population. Of the 104 samples analysed 44 showed troponin T concentrations above the manufacturer's quoted limit of detection. Age and gender differences in the median and 99th percentile troponin T concentration were observed. CONCLUSIONS: The new hs-TnT assay shows improved precision and sensitivity at very low troponin concentration. We have shown that a significant number of individuals in this cardio-healthy population had detectable circulating troponin concentration. With many apparently healthy people having detectable troponin, clinical judgement will become more important in interpreting troponin results.
No takes yet. Share an insight, caveat, or question.
Koerbin et al. (2010) conducted an observational in Cardio-healthy (n=104). Roche highly sensitive troponin T (hs-TnT) assay was evaluated on Detectable troponin T concentrations above the manufacturer's quoted limit of detection. The Roche highly sensitive troponin T assay met precision specifications, detecting circulating troponin in 44 of 104 individuals from a cardio-healthy reference population.
Synapse has enriched 10 related papers. Consider them for comparative context: